Current Imaging Strategies of Primary and Secondary Neoplasms of the Liver

 

 Buy Article Permissions and Reprints

ABSTRACT

This article details the diagnosis and imaging of primary and secondary neoplasms of the liver. Benign conditions that can mimic malignancy are also discussed, such as focal nodular hyperplasia and adenoma. Considerable attention is given to hepatoma, which is the most common primary hepatic tumor in the United States. The roles of magnetic resonance imaging, computed tomography, and ultrasound are evaluated, with recommendations for their effective use. Pitfalls in imaging related to posttreatment changes and unusual patterns of metastatic disease are illustrated.

REFERENCES

• 1 American Cancer Society .Cancer Facts and Figures 2005. Atlanta, GA; American Cancer Society 2005
  Google Scholar
• 2 Chen C J, Yu M W, Liaw Y F. Epidemiological characteristics and risk factors of hepatocellular carcinoma.  J Gastroenterol Hepatol. 1997;  12 S294-S308
  PubMedGoogle Scholar
• 3 Michielsen P P, Francque S M, van Dongen J L. Viral hepatitis and hepatocellular carcinoma.  World J Surg Oncol. 2005;  3 27
  CrossrefPubMedGoogle Scholar
• 4 Beasley R P, Hwang L Y, Lin C C, Chien C S. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan.  Lancet. 1981;  2 1129-1133
  PubMedGoogle Scholar
• 5 Cha C, Dematteo R P. Molecular mechanisms in hepatocellular carcinoma development.  Best Pract Res Clin Gastroenterol. 2005;  19 25-37
  CrossrefPubMedGoogle Scholar
• 6 Karayiannis P. Hepatitis D virus.  Rev Med Virol. 1998;  8 13-24
  CrossrefPubMedGoogle Scholar
• 7 McGlynn K A, London W T. Epidemiology and natural history of hepatocellular carcinoma.  Best Pract Res Clin Gastroenterol. 2005;  19 3-23
  CrossrefPubMedGoogle Scholar
• 8 Moradpour D, Blum H E. Pathogenesis of hepatocellular carcinoma.  Eur J Gastroenterol Hepatol. 2005;  17 477-483
  CrossrefPubMedGoogle Scholar
• 9 Daniele B, Bencivenga A, Megna A S, Tinessa V. Alpha-fetoprotein and ultrasonography screening for hepatocellular carcinoma.  Gastroenterology. 2004;  127(suppl 1) S108-S112
  CrossrefPubMedGoogle Scholar
• 10 Schefer H, Mattmann S, Joss R A. Hereditary persistence of alpha-fetoprotein: case report and review of the literature.  Ann Oncol. 1998;  9 667-672
  CrossrefPubMedGoogle Scholar
• 11 Peng S Y, Chen W J, Lai P L, Jeng Y M, Sheu J C, Hsu H C. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.  Int J Cancer. 2004;  112 44-50
  CrossrefPubMedGoogle Scholar
• 12 Oliver III J H, Baron R L, Federle M P, Rockette Jr H E. Detecting hepatocellular carcinoma: value of unenhanced or arterial phase CT imaging or both used in conjunction with conventional portal venous phase contrast-enhanced CT imaging.  AJR Am J Roentgenol. 1996;  167 71-77
  PubMedGoogle Scholar
• 13 Scharitzer M, Schima W, Schober E et al.. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.  J Comput Assist Tomogr. 2005;  29 181-190
  CrossrefPubMedGoogle Scholar
• 14 Saini S, Edelman R R, Sharma P et al.. Blood-pool MR contrast material for detection and characterization of focal hepatic lesions: initial clinical experience with ultrasmall superparamagnetic iron oxide (AMI-227).  AJR Am J Roentgenol. 1995;  164 1147-1152
  PubMedGoogle Scholar
• 15 The Cancer of the Liver Italian Program (CLIP) investigators . A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients.  Hepatology. 1998;  28 751-755
  CrossrefPubMedGoogle Scholar
• 16 Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).  J Gastroenterol. 2003;  38 207-215
  CrossrefPubMedGoogle Scholar
• 17 Liovet J M, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the Barcelona clinic liver cancer staging classification.  Semin Liver Dis. 1999;  19 329-338
  PubMedGoogle Scholar
• 18 American Joint Committee on Cancer .Liver (including intrahepatic bile ducts). In: Green FL, Page DL, Fleming ID, et al AJCC Staging Manual. 6th ed. New York; Springer 2002: 131-138
  Google Scholar
• 19 Craig J R, Peters R L, Edmondson H A, Omata M. Fibrolamellar carcinoma of the liver: a tumor of adolescents and young adults with distinctive clinico-pathologic features.  Cancer. 1980;  46 372-379
  CrossrefPubMedGoogle Scholar
• 20 El-Serag H B, Davila J A. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.  Hepatology. 2004;  39 798-803
  CrossrefPubMedGoogle Scholar
• 21 McLarney J K, Rucker P T, Bender G N et al.. Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation.  Radiographics. 1999;  19 453-471
  PubMedGoogle Scholar
• 22 Gabata T, Matsui O, Kadoya M et al.. Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance.  Abdom Imaging. 1998;  23 309-313
  CrossrefPubMedGoogle Scholar
• 23 Altaee M Y, Johnson P J, Farrant J M, Williams R. Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma.  Cancer. 1991;  68 2051-2055
  PubMedGoogle Scholar
• 24 Hayasaka K, Amoh K, Kakisaka A, Mito M. MRI appearance of thorotrast-induced cholangiocarcinoma in a case of thorotrastosis.  Radiat Med. 1993;  11 60-62
  PubMedGoogle Scholar
• 25 Yalcin S. Diagnosis and management of cholangiocarcinomas: a comprehensive review.  Hepatogastroenterology. 2004;  51 43-50
  PubMedGoogle Scholar
• 26 Di Cesare E, Puglielli E, Michelini O et al.. Malignant obstructive jaundice: comparison of MRCP and ERCP in the evaluation of distal lesions.  Radiol Med (Torino). 2003;  105 445-453
  PubMedGoogle Scholar
• 27 Yeh T S, Jan Y Y, Tseng J H et al.. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings.  Am J Gastroenterol. 2000;  95 432-440
  CrossrefPubMedGoogle Scholar
• 28 Gore R M, Yaghmai V, Newmark G M, Berlin J W, Miller F H. Imaging benign and malignant disease of the gallbladder.  Radiol Clin North Am. 2002;  40 1307-1323
  PubMedGoogle Scholar
• 29 Paraskevopoulos J A, Dennison A R, Johnson A G. Primary carcinoma of the gallbladder.  HPB Surg. 1991;  4 277-289
  PubMedGoogle Scholar
• 30 Crippa S, Bovo G, Romano F, Mussi C, Uggeri F. Melanoma metastatic to the gallbladder and small bowel: report of a case and review of the literature.  Melanoma Res. 2004;  14 427-430
  PubMedGoogle Scholar
• 31 Chiu O, Frank J D, Dow C A. Hepatic angiosarcoma: detection with computed tomography.  Australas Radiol. 2005;  49 163-165
  CrossrefPubMedGoogle Scholar
• 32 Hozo I, Miric D, Bojic L et al.. Liver angiosarcoma and hemangiopericytoma after occupational exposure to vinyl chloride monomer.  Environ Health Perspect. 2000;  108 793-795
  PubMedGoogle Scholar
• 33 Azodo M V, Gutierrez O H, Greer T. Thorotrast-induced ruptured hepatic angiosarcoma.  Abdom Imaging. 1993;  18 78-81
  CrossrefPubMedGoogle Scholar
• 34 Harrison J R, Faust T W, Blackstone M O. Hepatic angiosarcoma: an unusual cause of congestive heart failure.  South Med J. 2001;  94 336-338
  PubMedGoogle Scholar
• 35 Emre S, McKenna G J. Liver tumors in children.  Pediatr Transplant. 2004;  8 632-638
  CrossrefPubMedGoogle Scholar
• 36 Fukuzawa R, Hata J, Hayashi Y, Ikeda H, Reeve A E. Beckwith-Wiedemann syndrome-associated hepatoblastoma.  Pediatr Dev Pathol. 2003;  6 299-306
  PubMedGoogle Scholar
• 37 Yamazaki M, Ryu M, Okazumi S et al.. Hepatoblastoma in an adult: a case report and clinical review of literatures.  Hepatol Res. 2004;  30 182-188
  PubMedGoogle Scholar
• 38 Choi B Y, Nguyen M H. The diagnosis and management of benign hepatic tumors.  J Clin Gastroenterol. 2005;  39 401-412
  CrossrefPubMedGoogle Scholar
• 39 Yoon S S, Charny C K, Fong Y et al.. Diagnosis, management, and outcomes of 115 patients with hepatic hemangioma.  J Am Coll Surg. 2003;  197 392-402
  CrossrefPubMedGoogle Scholar
• 40 Bonanno N, Baldari S, Cerrito A et al.. Diagnosis of hepatic hemangiomas with 99mTc-labeled red blood cell scanning: value of SPECT.  J Nucl Biol Med. 1991;  35 135-140
  PubMedGoogle Scholar
• 41 Kim T, Federle M P, Baron R L, Peterson M S, Kawamori Y. Discrimination of small hepatic hemangiomas from hypervascular malignant tumors smaller than 3 cm with three-phase helical CT.  Radiology. 2001;  219 699-706
  PubMedGoogle Scholar
• 42 Yan F H, Zeng M S, Zhou K R. Role and pitfalls of hepatic helical multi-phase CT scanning in differential diagnosis of small hemangioma and small hepatocellular carcinoma.  World J Gastroenterol. 1998;  4 343-347
  PubMedGoogle Scholar
• 43 Shortell C K, Schwartz S I. Hepatic adenoma and focal nodular hyperplasia.  Surg Gynecol Obstet. 1991;  173 426-431
  PubMedGoogle Scholar
• 44 Minami Y, Kudo M, Kawasaki T et al.. Intrahepatic huge hematoma due to rupture of small hepatocellular adenoma: a case report.  Hepatol Res. 2002;  23 145-151
  PubMedGoogle Scholar
• 45 Grazioli L, Federle M P, Ichikawa T, Balzano E, Nalesnik M, Madariaga J. Liver adenomatosis: clinical, histopathologic, and imaging findings in 15 patients.  Radiology. 2000;  216 395-402
  PubMedGoogle Scholar
• 46 Grazioli L, Federle M P, Brancatelli G, Ichikawa T, Olivetti L, Blachar A. Hepatic adenomas: imaging and pathologic findings.  Radiographics. 2001;  21 877-892
  CrossrefPubMedGoogle Scholar
• 47 Paulson E K, McClellan J S, Washington K, Spritzer C E, Meyers W C, Baker M E. Hepatic adenoma: MR characteristics and correlation with pathologic findings.  AJR Am J Roentgenol. 1994;  163 113-116
  PubMedGoogle Scholar
• 48 Reddy K R, Kligerman S, Levi J et al.. Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome.  Am Surg. 2001;  67 173-178
  PubMedGoogle Scholar
• 49 Blachar A, Federle M P, Ferris J V et al.. Radiologists' performance in the diagnosis of liver tumors with central scars by using specific CT criteria.  Radiology. 2002;  223 532-539
  CrossrefPubMedGoogle Scholar
• 50 Finley A C, Hosey J R, Noone T C, Shackelford D M, Varadarajulu S. Multiple focal nodular hyperplasia syndrome: diagnosis with dynamic, gadolinium-enhanced MRI.  Magn Reson Imaging. 2005;  23 511-513
  PubMedGoogle Scholar
• 51 Basaran C, Karcaaltincaba M, Akata D et al.. Fat-containing lesions of the liver: cross-sectional imaging findings with emphasis on MRI.  AJR Am J Roentgenol. 2005;  184 1103-1110
  PubMedGoogle Scholar
• 52 Krakora G A, Coakley F V, Williams G, Yeh B M, Breiman R S, Qayyum A. Small hypoattenuating hepatic lesions at contrast-enhanced CT: prognostic importance in patients with breast cancer.  Radiology. 2004;  233 667-673
  PubMedGoogle Scholar
• 53 Mortele K J, Ros P R. Cystic focal liver lesions in the adult: differential CT and MR imaging features.  Radiographics. 2001;  21 895-910
  PubMedGoogle Scholar
• 54 Brannigan M, Burns P N, Wilson S R. Blood flow patterns in focal liver lesions at microbubble-enhanced US.  Radiographics. 2004;  24 921-935
  CrossrefPubMedGoogle Scholar
• 55 Li L, Liu L Z, Xie Z M et al.. Multi-phasic CT arterial portography and CT hepatic arteriography improving the accuracy of liver cancer detection.  World J Gastroenterol. 2004;  10 3118-3121
  PubMedGoogle Scholar
• 56 Kim H C, Kim T K, Sung K B et al.. CT during hepatic arteriography and portography: an illustrative review.  Radiographics. 2002;  22 1041-1051
  PubMedGoogle Scholar

Linda FieldingM.D. 

Department of Radiology

Denver Health Medical Center, 777 Bannock Street, MC 0024, Denver, CO 80204